论药品价格垄断及其法律规制

On the Legal Regulation for the Monopoly of Pharmaceutical Price

我国药品价格垄断呈现出原料药垄断、垄断行为的横向性行政性等特征,对当前我国医药行业的健康发展和竞争环境的稳定有序极为不利。本文梳理我国相关法律规定,发现在药价垄断规制领域长期存在无法可依、有法难依的问题。通过借鉴欧美相关法律规定,我国需要完善和增加现有法律条款,细化已有法律的笼统性规定,协调解决进口专利药品的不可及性。

The monopoly of pharmaceutical price in China is characterized by the propelling power of APIs, the transverse nature of monopoly behavior, the uncontrollability of patent drug prices and administration, which are extremely unfavorable to the healthy development of the pharmaceutical industry and the orderly circumstance of stabilized competition. This article intends to comb the relevant China’s laws and regulations, and finds that there are long-standing problems in the field of monopoly of pharmaceutical price regulation. By drawing lessons from the relevant European and American laws and regulations, it is essential for China to improve and increase the existing legal provisions, refine the general provisions of existing laws, and coordinate the solution of the inaccessibility of imported patented drugs.